This is a Validated Antibody Database (VAD) review about mouse Cd200r1, based on 6 published articles (read how Labome selects the articles), using Cd200r1 antibody in all methods. It is aimed to help Labome visitors find the most suited Cd200r1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cd200r1 synonym: CD200R; Mox2r; OX2R

Miltenyi Biotec
human monoclonal (REA850)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s6
Miltenyi Biotec Cd200r1 antibody (Miltenyi Biotec, 130-112-529) was used in immunohistochemistry - frozen section on mouse samples (fig s6). Sci Rep (2022) ncbi
Bio-Rad
rat monoclonal (OX-110)
  • flow cytometry; human; loading ...; fig 5e
Bio-Rad Cd200r1 antibody (Bio-Rad, OX-110) was used in flow cytometry on human samples (fig 5e). Nat Commun (2020) ncbi
BioLegend
rat monoclonal (OX-110)
  • flow cytometry; mouse; loading ...; fig s1f
BioLegend Cd200r1 antibody (Biolegend, 123907) was used in flow cytometry on mouse samples (fig s1f). Cell (2019) ncbi
rat monoclonal (OX-110)
  • flow cytometry; mouse
BioLegend Cd200r1 antibody (Biolegend, OX-110) was used in flow cytometry on mouse samples . Biochem Biophys Res Commun (2015) ncbi
Invitrogen
rat monoclonal (OX110)
  • flow cytometry; mouse; fig 5c
In order to show that CD326(lo)CD103(lo)CD11b(lo) dermal dendritic cells respond to thymic stromal lymphopoietin, Invitrogen Cd200r1 antibody (eBioscience, OX110) was used in flow cytometry on mouse samples (fig 5c). J Immunol (2014) ncbi
rat monoclonal (OX-110)
  • flow cytometry; mouse; fig 5c
In order to show that CD326(lo)CD103(lo)CD11b(lo) dermal dendritic cells respond to thymic stromal lymphopoietin, Invitrogen Cd200r1 antibody (eBioscience, OX110) was used in flow cytometry on mouse samples (fig 5c). J Immunol (2014) ncbi
R&D Systems
domestic goat polyclonal
  • immunohistochemistry; mouse; 1:25; fig 3i
R&D Systems Cd200r1 antibody (R&D Systems, AF2554) was used in immunohistochemistry on mouse samples at 1:25 (fig 3i). Cancer Res (2021) ncbi
Articles Reviewed
  1. Kinkhabwala A, Herbel C, Pankratz J, Yushchenko D, R xfc berg S, Praveen P, et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep. 2022;12:1911 pubmed publisher
  2. Khan I, Del Guzzo C, Shao A, Cho J, Du R, Cohen A, et al. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K. Cancer Res. 2021;81:5021-5032 pubmed publisher
  3. Gasser P, Tarchevskaya S, Guntern P, Brigger D, Ruppli R, Zbären N, et al. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nat Commun. 2020;11:165 pubmed publisher
  4. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  5. Nishikado H, Fujimura T, Taka H, Mineki R, Ogawa H, Okumura K, et al. Cysteine protease antigens cleave CD123, the α subunit of murine IL-3 receptor, on basophils and suppress IL-3-mediated basophil expansion. Biochem Biophys Res Commun. 2015;460:261-6 pubmed publisher
  6. Ochiai S, Roediger B, Abtin A, Shklovskaya E, Fazekas de St Groth B, Yamane H, et al. CD326(lo)CD103(lo)CD11b(lo) dermal dendritic cells are activated by thymic stromal lymphopoietin during contact sensitization in mice. J Immunol. 2014;193:2504-11 pubmed publisher